CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Huahai Pharmaceutical Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Huahai Pharmaceutical Co., Ltd.
Xunqiao, Linhai City
Phone: +86 57685991096p:+86 57685991096 TAIZHOU, ZHJ  317024  China Ticker: 600521600521
Business Summary
Zhejiang Huahai Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, manufacture and sales of generic drugs, biological drugs, innovative drugs and specialty active pharmaceutical ingredients (APIs) in multiple dosage forms. The Company's pharmaceutical preparations and APIs cover cardiovascular, mental disorder, nervous system and anti-infection fields. The Company's products include irbesartan hydrochlorothiazide tablets, losartan potassium tablets, paroxetine hydrochloride tablets, sertraline hydrochloride tablets, oseltamivir phosphate capsules, linagliptin tablets, dabigatran etexilate capsules, pemetrexed disodium for injection, esomeprazole magnesium enteric-coated capsules, febuxostat tablets and torsemide injection. The Company also provides technical services and pharmaceutical import and export trade business.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8999 Services, not elsewhere classified
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HongLi 63 5/21/2019 5/21/2019
President, Director BaohuaChen 62 5/21/2019
Chief Financial Officer, Vice President MeiZhang 48 5/17/2022 6/19/2008
12 additional Officers and Directors records available in full report.

Business Names
Business Name
600521
Zhejiang Huahai Pharmaceutical Co., Ltd.

General Information
Number of Employees: 8,221 (As of 12/31/2023)
Outstanding Shares: 1,466,755,454 (As of 9/30/2024)
Shareholders: 73,698
Stock Exchange: SHA
Fax Number: +86 57685016010


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024